CompletedEarly Phase 1NCT05948020
Efficacy and Safety of Orally Administered Engineered Probiotics (CBT102-A) for the Treatment of Children With Phenylketonuria
Studying Classic phenylketonuria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Hospital of Fudan University
- Principal Investigator
- Wenhao ZhouChildren's Hospital of Fudan University
- Intervention
- CBT102-A capsule(biological)
- Enrollment
- 15 enrolled
- Eligibility
- 3-17 years · All sexes
- Timeline
- 2023 – 2024
Study locations (1)
- Children's Hospital of Fudan University, Shanghai, China
Collaborators
CommBio Therapeutics limited company
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05948020 on ClinicalTrials.govOther trials for Classic phenylketonuria
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07241234A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With PhenylketonuriaAgios Pharmaceuticals, Inc.
- RECRUITINGNANCT07194993PKU Protein RequirementsEmory University
- RECRUITINGNANCT07526909Effect of Different Meal Types Given Before Exercise on Plasma Amino Acid Levels and Metabolic Control Parameters in Classical Phenylketonuria Patients Undergoing Aerobic and Resistance ExercisesHacettepe University
- ACTIVE NOT RECRUITINGPHASE4NCT06780332Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to PalynziqBioMarin Pharmaceutical
- RECRUITINGNANCT01659749Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With PhenylketonuriaEmory University